1011-15-0 (1-(2-氟苯基)哌嗪,1-(2-Fluorophenyl)piperazine)

CAS号:
1011-15-0
中文名称:
1-(2-氟苯基)哌嗪
英文名称:
1-(2-Fluorophenyl)piperazine
安全信息:
分子式:
C10H13FN2
分子量:
180.222025632858

1-(2-氟苯基)哌嗪(1011-15-0)名称与标识符

名称

中文别名:
1-(2-氟苯基)哌嗪;1-(2-Fluorophenyl)piperazine 1-(2-氟苯基)哌嗪;1-2-氟苯基哌嗪;2-氨基-4-(对-甲苯基)-1H-吡咯-3-甲腈;邻氟苯基哌嗪;1-(2-氟苯基)哌嗪1-(2-氟苯基)哌嗪;1-(2-氟苯基)哌嗪,99%;
英文别名:
1-(2-Fluorophenyl)piperazine;EINECS 213-780-4;fluorophenylpiperazine;Piperazine,1-(o-fluorophenyl)- (7CI,8CI);1-(o-Fluorophenyl)piperazine;4-(2-Fluorophenyl)piperazine;N-(2-Fluorophenyl)piperazine;Piperazine,1-(2-fluorophenyl)-;RARECHEM AH CK 0103;1-(2-Fluorphenyl)-piperazine;2-(1-Piperazino)fluorobenzene;AKOS BBS-00003615;LABOTEST-BB LT00159366;Piperazine, 1-(2-fluorophenyl)-;1-(2-Fluorophenyl)-piperazine;1-(2-Fluoro-phenyl)-piperazine;IVTZRJKKXSKXKO-UHFFFAOYSA-N;(2-fluorophenyl)piperazine;oFPP;PubChem8573;1-(2-fluorophenyl)piperazinehydrochloride;2-fluorophenylpiperazine;2-Fluorophenyl piperazine;ortho-fluorophenylpiperazine;4-(fluorophenyl)piperazine;1-(2-flurophenyl)piperazine;KSC175;l-(2-fluorophenyl)-piperazine;SY004248;EN300-19576;F0728;AK-968/13034061;Z-L-LEUCINE-BETA-NAPHTHYLAMIDEMONOHYDRATE;BDBM50017457;BH-0401;J-000325;1-(2-fluorophenyl) piperazine;BIDD:GT0234;1011-15-0;CHEMBL9429;CS-0034837;DTXSID30143732;PD057595;NS00042111;MFCD00040726;AC-7147;SCHEMBL234734;1-(2-Fluorophenyl)piperazine, 97%;AKOS000101160;(2-fluoro-phenyl)-piperazine;AMY23149;FT-0605539;A16252;F2190-0348;STK397246;DB-024572;

标识符

MDL:
MFCD00040726
InChIKey:
IVTZRJKKXSKXKO-UHFFFAOYSA-N
Inchi:
1S/C10H13FN2/c11-9-3-1-2-4-10(9)13-7-5-12-6-8-13/h1-4,12H,5-8H2
SMILES:
FC1C=CC=CC=1N1CCNCC1
BRN:
611787

1-(2-氟苯基)哌嗪(1011-15-0)物化性质

实验特性

  • LogP : 1.62910
  • PSA : 15.27000
  • 折射率 : 1.555-1.558
  • 沸点 : 93°C/0.5mmHg(lit.)
  • 熔点 : 47.0 to 51.0 deg-C
  • 闪点 : >230 °F
  • 颜色与性状 : 未确定。
  • 溶解性 : 未确定
  • 敏感性 : Air Sensitive
  • 密度 : 1.141

计算特性

  • 精确分子量 : 180.10600
  • 氢键供体数量 : 1
  • 氢键受体数量 : 3
  • 可旋转化学键数量 : 1
  • 同位素质量 : 180.106
  • 重原子数量 : 13
  • 复杂度 : 157
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 1.5
  • 互变异构体数量 : 无
  • 表面电荷 : 0
  • 拓扑分子极性表面积 : 15.3

1-(2-氟苯基)哌嗪(1011-15-0)国际标准相关数据

EINECS:
213-780-4

1-(2-氟苯基)哌嗪(1011-15-0)海关数据

海关编码:
2933599090
海关数据:

中国海关编码:

2933599090

概述:

2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

申报要素:

品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期

Summary:

2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

1-(2-氟苯基)哌嗪(1011-15-0)推荐厂家 更多厂家(21)

公司名称手机号/电话联系人QQ微信询单
上海瀚思化工有限公司 18939883912
021-34536277
顾经理 3003949364
询单
铼博(上海)生化科技有限公司 13311756052
021-60536361 13311756052 13311756131
张经理 2851717387
询单
上海一基实业有限公司 13311756052
021-60526763 13311756052 13311756131
胡经理 2355265332
询单
上海一基实业有限公司 13311756131
021-60548336 QQ:2355265332 QQ:2851717387
胡经理 2355265332
询单
南通众合化工新材料有限公司 18762756250
0513-55074056
胡经理 2369399482
询单
赫澎(上海)生物科技有限公司 13122891558
186-16545970
张硕 3418426269
询单
深圳市瑞吉特生物科技有限公司 15813841136
0755-89459231
钦先生 1029374309
询单
金锦乐(湖南)化学有限公司 金锦乐 1226360695
询单
JACS-郑州杰克斯化工产品有限公司 15981966935
0371-86259281
杰克斯JACS 893596907
询单
上海依赫生物科技有限公司 17721395025
021-68882955
张经理 2423903095
询单

1-(2-氟苯基)哌嗪(1011-15-0)参考资料

Reaxys RN:
611787
Beilstein:
23(5)1,173
PubChem CID:

1-(2-氟苯基)哌嗪(1011-15-0) MSDS

基础信息

Name:1-(2-Fluorophenyl)piperazine 97%(GC) Material Safety Data Sheet
Synonym:None listed
CAS:1011-15-0
Section 1 - Chemical Product ? MSDS Name:1-(2-Fluorophenyl)piperazine 97%(GC) Material Safety Data Sheet
Synonym:None listed

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS#Chemical NamecontentEINECS#
1011-15-01-(2-Fluorophenyl)piperazine97213-780-4
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
? EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea.
Inhalation:
Causes respiratory tract irritation. Can produce delayed pulmonary edema.
Chronic:
Effects may be delayed.

Section 4 - FIRST AID MEASURES
? Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
? General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Vapors may be heavier than air. They can spread along the ground and collect in low or confined areas.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
? General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Clean up spills immediately, observing precautions in the Protective Equipment section. Provide ventilation.

Section 7 - HANDLING and STORAGE
? Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Use with adequate ventilation. Wash clothing before reuse.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
? Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 1011-15-0: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES
?
Physical State: Clear liquid
Color: white to pale yellow
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 150 deg C
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: 109 deg C ( 228.20 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Not available.
Specific Gravity/Density: 1.141 g/cm3
Molecular Formula: C10H13FN2
Molecular Weight: 180.22

Section 10 - STABILITY AND REACTIVITY
? Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported.

Section 11 - TOXICOLOGICAL INFORMATION
? RTECS#:
CAS# 1011-15-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-(2-Fluorophenyl)piperazine - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION
?

Section 13 - DISPOSAL CONSIDERATIONS
? Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION
?
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION
?
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 1011-15-0: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 1011-15-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1011-15-0 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A